As of September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A carries a market capitalization of 3.23B, placing it among publicly traded companies globally. Its enterprise value stands at 2.52B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.23B |
| Enterprise Value | 2.52B |
Guangdong Transtek Medical Electronics Co. Ltd. Class A's next confirmed earnings release is scheduled for April 29, 2027.
| Earnings Date | 4/29/2027 |
As of September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A has 218.93M shares outstanding.
| Shares Outstanding | 218.93M |
As of September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A trades at a trailing price-to-earnings ratio of 31.96. The price-to-sales ratio is 3.07, and the price-to-book ratio stands at 2.90.
| PE Ratio | 31.96 |
| PS Ratio | 3.07 |
| PB Ratio | 2.90 |
| P/TBV Ratio | 3.04 |
As of September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A trades at an EV/EBITDA multiple of 23.03 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.40 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 23.03 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 2.52B versus a market cap of 3.23B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 2.40 |
| EV / EBITDA | 23.03 |
| EV / EBIT | 23.03 |
As of September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A maintains a current ratio of 2.76, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.72, indicating elevated leverage, while an interest coverage ratio of -261.47 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.76 |
| Quick Ratio | 1.97 |
| Debt / Equity | 3.72 |
| Debt / EBITDA | 0.37 |
| Interest Coverage | -261.47 |
Over the twelve months ended September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A posted a return on equity (ROE) of 9.51, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 8.90 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.77, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.01, useful for judging operating efficiency across full business cycles. The company generates approximately 963,669.26 in revenue per employee across its workforce of 1,089.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.39 indicates how many times Guangdong Transtek Medical Electronics Co. Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 9.51 |
| Return on Assets (ROA) | 6.77 |
| Return on Invested Capital (ROIC) | 8.90 |
| Return on Capital Employed (ROCE) | 9.01 |
| Revenue Per Employee | 963,669.26 |
| Employee Count | 1,089.00 |
| Inventory Turnover | 7.39 |
Over the twelve months ended September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A recorded 7.74M in income tax expense. That works out to an effective tax rate of 7.24, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 106.91M, leaving 100.84M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 7.74M |
| Effective Tax Rate | 7.24 |
As of the close on November 17, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A's stock has declined approximately 16.80% over the past 52 weeks. The 50-day moving average sits at 14.75, while the 200-day moving average is 14.13.
| 52-Week Price Change | -16.80% |
| 50-Day Moving Average | 14.75 |
| 200-Day Moving Average | 14.13 |
Over the twelve months ended September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A generated 1.05B in revenue and converted that into 100.84M in net income, yielding earnings per share of 0.45. EBITDA reached 109.32M, while operating income came in at 142.54M.
| Revenue | 1.05B |
| Gross Profit | 376.13M |
| Operating Income | 142.54M |
| Pretax Income | 106.91M |
| Net Income | 100.84M |
| EBITDA | 109.32M |
| EBIT | 109.32M |
| Earnings Per Share (EPS) | 0.45 |
As of September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A holds 730.44M in cash and equivalents against 40.59M in total debt, resulting in a net debt position of -76.62M. Total book value stands at 1.11B, with working capital of 654.13M providing operational flexibility.
| Cash & Cash Equivalents | 730.44M |
| Total Debt | 40.59M |
| Net Debt | -76.62M |
| Equity (Book Value) | 1.11B |
| Book Value Per Share | 5.08 |
| Working Capital | 654.13M |
These figures cover the twelve months ended September 30, 2026.
| Capital Expenditures | -13.94M |
Over the twelve months ended September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A posted a gross margin of 35.84, reflecting its pricing power and cost economics. The operating margin of 13.58 and net profit margin of 9.61 provide insight into operational efficiency.
| Gross Margin | 35.84 |
| Operating Margin | 13.58 |
| Pretax Margin | 10.19 |
| Profit Margin | 9.61 |
| EBITDA Margin | 10.42 |
Over the twelve months ended September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A paid dividends of 0.13 per share. The dividend payout ratio of 29.19 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 3.25, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Guangdong Transtek Medical Electronics Co. Ltd. Class A shareholders.
| Dividend Per Share | 0.13 |
| Payout Ratio | 29.19 |
| Shareholder Yield | 3.25 |
Guangdong Transtek Medical Electronics Co. Ltd. Class A's most recent stock split took place on April 18, 2017 with a 5:16 split ratio.
| Last Split Date | 4/18/2017 |
| Split Ratio | 5:16 |
As of September 30, 2026, Guangdong Transtek Medical Electronics Co. Ltd. Class A has an Altman Z-Score of 6.66, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.66 |
Already premium?